A product with high peptide purity but poorly characterized copper content may not have the same activity as a properly characterized GHK-Cu complex
self-monitor BG daily | | Sulfonylureas (glipizide, glimepiride, glyburide) | Pharmacodynamic: additive insulin release | Hypoglycemia risk | Major | Reduce sulfonylurea 50% at initiation
These medications are not a cosmetic solution
Resources We Trust Cleveland Clinic: Weight Loss Medications Mayo Clinic: Weight Loss: 6 Strategies for Success Harvard Health Publishing: Intensive Lifestyle Change Obesity Medicine Association: Weight Loss Medication Side Effects: Know Before You Start Johns Hopkins Medicine : Intensive Behavioral Therapy for Obesity Sannidhi D et al
Si estas estrategias no resultan en mejora significativa despus de 4-6 semanas, debe considerarse la evaluacin de causas alternativas de fatiga o, en consulta con el mdico, la posibilidad de cambiar a un agente alternativo dentro o fuera de la clase GLP-1
Generally, apply GHK-Cu at night and keep strong actives like retinoids, exfoliating acids, or vitamin C to a different time of day or alternate nights